Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2003 Dec 26;101(1):2–3. doi: 10.1073/pnas.0307281101

Alcohol and inhibitory receptors: Unexpected specificity from a nonspecific drug

R A Harris 1,*, S J Mihic 1
PMCID: PMC314125  PMID: 14695895

It is remarkable that a simple two-carbon molecule like ethyl alcohol produces the many neurological, physiological, and societal effects that result from alcohol (ethanol) use and misuse. It is the least potent of all drugs, requiring concentrations of 10-20 mM to produce intoxication in humans and 100-200 mM to produce anesthesia in experimental animals (1, 2). Because of the limited structural information that can be obtained from such a simple molecule and the high concentrations required, a nonspecific or nonreceptor-mediated mechanism of action was considered likely, and, as a result, early studies focused on the actions of alcohol on physical properties of membrane lipids. More recently, the search for sites of action shifted from lipids to proteins, but the identification of brain proteins that are clearly affected by ethanol at concentrations of 10-20 mM has proven remarkably elusive. For reference, a moderately intoxicating blood alcohol level of 0.08% (80 mg/dl) is equivalent to an ethanol concentration of 17 mM. In 1986 an important first step toward defining targets of alcohol action was taken when three groups demonstrated that intoxicating concentrations of ethanol enhance the function of γ-aminobutyric acid type A (GABAA) receptors, the major inhibitory neurotransmitter receptors in the brain (3-5). One of these studies also showed that this action was missing in a line of mice (short-sleep mice) exhibiting genetic resistance to alcohol actions, suggesting the existence of alcohol-sensitive and alcohol-resistant subtypes of GABAA receptors (3). Despite the numerous electrophysiological studies stimulated by these studies, there is no clear understanding of what makes a GABAA receptor sensitive to low millimolar concentrations of ethanol and indeed many studies find either no effect of ethanol or effects only at concentrations of ≈100 mM or more (6).

Receptor Composition Determines Sensitivity to Ethanol

The report by Wallner et al. (7) in a recent issue of PNAS and a previous study by Sundstrom-Poromaa et al. (8) provide a glimmer of hope for understanding the molecular basis and physiological importance of alcohol-sensitive and -resistant receptors. The findings of Wallner et al. (7) demonstrate that high alcohol sensitivity of GABAA receptors requires the coexpression of both δ and β3 subunits. Replacing the δ subunit with γ2, or the β3 subunit with β2, markedly decreases the alcohol sensitivities of GABAA receptors. In the Wallner et al. (7) study, receptors composed of rat α4β2δ subunits were insensitive to ethanol concentrations <10 mM, in contrast to the findings made by Sundstrom-Poromaa et al. (8) in which EtOH concentrations of 1 and 3 mM produced marked enhancement of α4β2δ receptor function. In the latter study, mouse α4, rat β2, and human δ subunits were used, whereas rat α4 and δ subunits were used in the Wallner et al. (7) study. Thus, the differences in alcohol sensitivity observed may be caused by either species-dependent differences in subunit sequences or perhaps differences in the extent of subunit expression, which could affect receptor composition or density. Nevertheless, data from both studies lead to the surprising conclusion that alcohol has a more demanding receptor subunit composition requirement than sedative-hypnotic drugs such as barbiturates, which affect GABAA receptors composed of a wide variety of subunit combinations. The δ subunit may play an important role in determining the enhancing actions of modulatory agents other than alcohol. Lees and Edwards (9) showed that incorporation of δ subunits into receptors markedly enhance responses of GABAA receptors to the volatile anesthetic isoflurane.

Differences in alcohol sensitivity may be due to species-specific subunit sequences or receptor composition.

The key physiological implication, which is discussed in detail by Wallner et al. (7), is that alcohol likely acts on specific extrasynaptic responses, rather than on synaptic receptors (which contain γ and not δ subunits). This work raises two key questions for future study: (i) what is the molecular basis of the ethanol-protein interaction that results in alcohol modulation of GABAA receptor function? and (ii) which behavioral actions of alcohol are mediated by enhancement of the function of extra-synaptic GABAA receptors? The answer to the first question may well provide tools to answer the second. There is considerable evidence that the effects of high (anesthetic) concentrations of n-alcohols on GABAA receptors are caused by their binding in a water-filled protein cavity between the second and third transmembrane segments of the receptor subunits (10, 11). The α subunits appear to be particularly important for this interaction, but there is also a role for β subunits and perhaps also for γ (12). The high alcohol sensitivities of receptors containing β3 and δ subunits provide the opportunity to determine whether this same binding cavity is found in all or some of the subunits of this receptor. In addition, such studies also raise the possibility of constructing mutant receptors in which alcohol sensitivity is removed. These mutant receptors can then be introduced into ”knock-in” mice to provide a powerful tool for associating alcohol effects on a particular receptor subtype with specific behavioral actions of alcohol. As reviewed by Wallner et al. (7), this approach has linked β3 subunits to the anesthetic actions of etomidate.

Knockouts and Knock-ins

Although less elegant than the knock-in approach, traditional knockout mice may also be useful in linking behavioral actions to receptors. For example, ethanol enhancement of GIRK2 channel function was linked to the analgesic actions, but not other effects, of ethanol by using GIRK2 null mutant mice (13). In this regard, it might be useful to construct mice lacking the α4 subunit of the GABAA receptor. One could also breed together existing mutant mice lacking the δ and β3 subunits and the α4 knock-out mice when they are available to create multiple subunit knockouts of the GABAA receptor. Despite the considerable ethanol sensitivity of GABAA receptors containing the α6 subunit seen by Wallner et al. (7), results obtained from α6 knockout mice thus far are not encouraging, with the subunit exerting little effect on alcohol-induced sleep time, acute functional tolerance, withdrawal hyperexcitability, or protracted tolerance (14, 15). At this point in time, there appears to be no behavioral correlate for the enhancement of the α6-containing GABAA receptors by low concentrations of ethanol.

One of the overall goals of studies such as that of Wallner et al. (7) is to first identify molecular targets that are sensitive to concentrations of alcohol commonly achieved in vivo. Once such targets are identified, the next step is to determine whether those targets underlie specific actions of alcohol, such as reward, craving, tolerance, and dependence. Such information should allow targeted intervention to limit the neuronal damage, craving, loss of control, and relapse that characterize chronic alcoholism.

See companion article on page 15218 in issue 25 of volume 100.

References

  • 1.Naranjo, C. A. & Bremner, K. E. (1993) Addiction 88, 25-35. [PubMed] [Google Scholar]
  • 2.Fang, Z., Ionescu, P., Chortkoff, B. S., Kandel, L., Sonner, J., Laster, M. J. & Eger, E. I., 2nd (1997) Anesth. Analg. 84, 1042-1048. [DOI] [PubMed] [Google Scholar]
  • 3.Allan, A. M. & Harris, R. A. (1986) Life Sci. 39, 2005-2015. [DOI] [PubMed] [Google Scholar]
  • 4.Suzdak, P. D., Schwartz, R. D., Skolnick, P. & Paul, S. M. (1986) Proc. Natl. Acad. Sci. USA 83, 4071-4075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ticku, M. K., Lowrimore, P. & Lehoullier, P. (1986) Brain Res. Bull. 17, 123-126. [DOI] [PubMed] [Google Scholar]
  • 6.Mihic, S. J. (1999) Neurochem. Int. 35, 115-123. [DOI] [PubMed] [Google Scholar]
  • 7.Wallner, M., Hanchar, H. J. & Olsen, R. W. (2003) Proc. Natl. Acad. Sci. USA 100, 15218-15223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sundstrom-Poromaa, I., Smith, D. H., Gong, Q. H., Sabado, T. N., Li, X., Light, A., Wiedmann, M., Williams, K. & Smith, S. S. (2002) Nat. Neurosci. 5, 721-722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lees, G. & Edwards, M. D. (1998) Anesthesiology 88, 206-217. [DOI] [PubMed] [Google Scholar]
  • 10.Mihic, S. J., Ye, Q., Wick, M. J., Koltchine, V. V., Krasowski, M. D., Finn, S. E., Mascia, M. P., Valenzuela, C. F., Hanson, K. K., Greenblatt, E. P., et al. (1997) Nature 389, 385-389. [DOI] [PubMed] [Google Scholar]
  • 11.Mascia, M. P., Trudell, J. R. & Harris, R. A. (2000) Proc. Natl. Acad. Sci. USA 97, 9305-9310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ueno, S., Wick, M. J., Ye, Q., Harrison, N. L. & Harris, R. A. (1999) Br. J. Pharmacol. 127, 377-382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Blednov, Y. A., Stoffel, M., Chang, S. R. & Harris, R. A. (2001) J. Pharmacol. Exp. Ther. 298, 521-530. [PubMed] [Google Scholar]
  • 14.Homanics, G. E., Ferguson, C., Quinlan, J. J., Daggett, J., Snyder, K., Lagenaur, C., Mi, Z. P., Wang, X. H., Grayson, D. R. & Firestone, L. L. (1997) Mol. Pharmacol. 51, 588-596. [DOI] [PubMed] [Google Scholar]
  • 15.Homanics, G. E., Le, N. Q., Kist, F., Mihalek, R., Hart, A. R. & Quinlan, J. J. (1998) Alcohol. Clin. Exp. Res. 22, 259-265. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES